# | ||||
---|---|---|---|---|
1 | COPACETIC "COPD Pathology: Addressing Critical gaps, Early Treatment and Innovative Concepts" | 2008 | 4˙020˙859.00 | 2˙981˙143.00 |
2 | HANDOVER Improving the Continuity of patient care Through Identification and implementation of Novel patient handoff processes in Europe | 2008 | 3˙443˙100.00 | 2˙623˙200.00 |
3 | MDDANEURODEV Molecular coding and subset specification of dopamine neurons generating the the meso-limbic and nigro-striatal system | 2009 | 3˙420˙935.00 | 2˙582˙749.00 |
4 | CONCORD CONtrol of COmmunity-acquired MRSA: Rationale and Development of counteractions | 2009 | 3˙937˙759.00 | 2˙994˙192.00 |
5 | KINSIGN Guarding Genome Stability: Dynamic Control of Chromosome Segregation by Kinetochore Signalling Pathways | 2009 | 1˙572˙000.00 | 1˙572˙000.00 |
6 | MECHWNTSIGNALS Mechanisms of Wnt Signaling Initiation | 2009 | 1˙513˙800.00 | 1˙513˙800.00 |
7 | OPTIMISE OPtimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) | 2010 | 14˙900˙190.00 | 11˙187˙685.00 |
8 | SABDII Staphylococcus aureus biofilm dynamics and innate immunity | 2010 | 45˙000.00 | 45˙000.00 |
9 | MINDS Microvesicle-inspired drug delivery systems | 2010 | 1˙338˙000.00 | 1˙338˙000.00 |
10 | EURO-MOTOR European multidisciplinary ALS network identification to cure motor neuron degeneration | 2011 | 11˙939˙816.00 | 8˙994˙361.00 |
11 | PHARMACHILD Long-term PHARMacovigilance for Adverse effects in Childhood arthritis focussing on Immune modulatory drugs | 2011 | 3˙924˙102.00 | 2˙973˙976.00 |
12 | RETEBESKO Rechargeable Telemetry-Based Electrochemical Sensors: Kidney Oxygenation and health | 2011 | 238˙119.00 | 238˙119.00 |
13 | PRINTCART Bioprinting of novel hydrogel structures for cartilage tissue engineering | 2011 | 265˙944.00 | 265˙944.00 |
14 | VIRUSSHCREEN Discovery of novel aspects of host-pathogen interactions through the use of powerful genome-wide shRNA libraries | 2011 | 100˙000.00 | 100˙000.00 |
15 | EVOTAR Evolution and Transfer of Antibiotic Resistance | 2011 | 16˙044˙083.00 | 11˙997˙391.00 |
16 | R-GNOSIS Resistance in Gram-Negative Organisms: Studying Intervention Strategies | 2011 | 15˙654˙161.00 | 11˙999˙999.00 |
17 | SOUND PHARMA Image Guided Local Drug Delivery from Nanocarriers using Focused Ultrasound | 2011 | 2˙500˙000.00 | 2˙500˙000.00 |
18 | EUTRAIN EUropean TRanslational training for Autoimmunity & Immune manipulation Network | 2012 | 3˙762˙774.00 | 3˙762˙774.00 |
19 | SURFACE Gram positive Surface proteins in immune evasion | 2012 | 169˙535.00 | 169˙535.00 |
20 | MECHFXR "Towards FXR-mediated therapeutic intervention: Understanding how FXR integrates metabolic, endocrine and inflammatory signaling." | 2012 | 183˙805.00 | 183˙805.00 |
21 | TARGETMV TARGET MV: Proof of concept study to commercialise a microvesicle-based drug delivery system | 2012 | 158˙600.00 | 145˙210.00 |
22 | CIRCUMVENT Closing in on Runx3 and CXCL4 to open novel avenues for therapeutic intervention in systemic sclerosis | 2012 | 1˙500˙000.00 | 1˙500˙000.00 |
23 | TOP TOwards Personalized medicine: defining the role of the bone marrow microenvironment in multiple myeloma | 2012 | 274˙889.00 | 274˙889.00 |
24 | STEM-TECH STEM-TECH: Introducing proprietary stem cell marker technology for the life sciences market | 2013 | 163˙100.00 | 148˙280.00 |
25 | WNTSAPP WNT-mediated signal relay in stem cells and oncogenesis - from basic biology to applications | 2013 | 4˙000˙164.00 | 4˙000˙164.00 |
26 | ICONNECT Intracranial COnnection with Neural Networks for Enabling Communication in Total paralysis | 2013 | 2˙498˙829.00 | 2˙498˙829.00 |
27 | AUTOIMMUNITY RASGRP1 Functional analysis of RasGRP1 SNPs in autoimmune disease | 2013 | 259˙745.00 | 259˙745.00 |
28 | SWITCHR5-X4 Determinants of the switch from R5- to X4-tropic virus in HIV-1 infected individuals | 2013 | 183˙469.00 | 183˙469.00 |
29 | ASTERIX Advances in Small Trials dEsign for Regulatory Innovation and eXcellence | 2013 | 4˙141˙786.00 | 2˙999˙881.00 |
30 | SMALLVESSELMRI Towards understanding cerebral small vessel disease: Innovative, MRI-based, functional markers to discover the terra incognita between large vessels and macroscopic brain lesions | 2013 | 1˙499˙560.00 | 1˙499˙560.00 |
31 | CARPEDIEM Cardio Renal Paradigms ElucidateD through an International Exchange ScheMe | 2014 | 134˙400.00 | 134˙400.00 |
32 | FXR-IBD Industry-Academia exchange to further FXR-based therapeutic intervention and non-invasive diagnosis in Inflammatory Bowel Disease | 2014 | 1˙486˙100.00 | 1˙486˙100.00 |
33 | EXCELSIOR The Expression of CXC chemokine ligand 4 in Systemic Sclerosis and its Role in the regulation of immune and fibrotic responses | 2014 | 183˙469.00 | 183˙469.00 |
34 | MICROSCAP MicroRNA targeting to achieve Systemic Sclerosis Control and Prediction | 2014 | 175˙974.00 | 175˙974.00 |
L'Ente universitair medisch centrum utrecht partecipato anche in questi progetti.